Side-alternativer

Back to Projects database

Medicine Bow CTL

Brief description:

Medicine Bow CTL: Read more; Capture Method:
Pre-combustion
Capture Technology:
Other
Capital cost:
Financial support:
finsup
--> Volume:
3.6 million tonnes; 41.6032207 -106.912251

Facts:

Country: USA

Project type: Capture Storage

Scale: Large

Status: Feed study

Year of operation 2015

Industry: Coal to liquid

Capture method: Pre-combustion

Capture technology: Other

New or retrofit: New

Transport of CO2 by: Pipeline

Storage site:

Rocky Mountain Region

Type of storage: EOR

Volume: 3.6 million tonnes/CO2

Wyoming coal mine

Medicine Bow Fuel and Power (MBFP) is planning to build and operate a new coal-to-liquids plant near a coal mine mouth in Carbon County in Wyoming, which will capture around 3.6 million tonnes per annum of CO2 using Selexol pre-combustion capture technology (an acid gas solvent).

The coal feedstock will be used to produce both methanol and gasoline, and the captured CO2 will be transported via pipeline for use in EOR projects, such as Denbury Resources' operations at oilfields in the Rocky Mountain Region. A commercial deal for the off-take of CO2 has already been signed.

A number of formal agreements have been reached with providers of technology, including SNC-Lavalin for building, commissioning and testing the CTL facility, and Honeywell for Selexol capture technology. The project has also contracted ExxonMobil for its Methanol to Gasoline (MTG) process technology.

MBFP is owned by DKRW Advanced Fuels, of which Arch Coal – which is supplying the coal feedstock – is an investor. The nearby mine is thought to have 180 million tonnes of coal reserves.

A surplus of clean power produced at the plant – around 45MW at first – will be sold to local electricity suppliers.

Timing

The project is scheduled to begin operating in 2015. It has already obtained permits to construct and operate the facility and the coal mine, which will provide the feedstock. The FEED study for the project was conducted by SNC-Lavalin.